AU1711088A - Hiv related human retrovirus strain with cloned nucleotide sequence and applications thereof - Google Patents
Hiv related human retrovirus strain with cloned nucleotide sequence and applications thereofInfo
- Publication number
- AU1711088A AU1711088A AU17110/88A AU1711088A AU1711088A AU 1711088 A AU1711088 A AU 1711088A AU 17110/88 A AU17110/88 A AU 17110/88A AU 1711088 A AU1711088 A AU 1711088A AU 1711088 A AU1711088 A AU 1711088A
- Authority
- AU
- Australia
- Prior art keywords
- applications
- nucleotide sequence
- related human
- human retrovirus
- hiv related
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 239000002773 nucleotide Substances 0.000 title 1
- 125000003729 nucleotide group Chemical group 0.000 title 1
- 241001430294 unidentified retrovirus Species 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
- C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
- C07K16/1036—Retroviridae, e.g. leukemia viruses
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/15011—Lentivirus, not HIV, e.g. FIV, SIV
- C12N2740/15021—Viruses as such, e.g. new isolates, mutants or their genomic sequences
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/15011—Lentivirus, not HIV, e.g. FIV, SIV
- C12N2740/15022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Virology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Immunology (AREA)
- Biophysics (AREA)
- Zoology (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Wood Science & Technology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Hematology (AREA)
- Oncology (AREA)
- General Engineering & Computer Science (AREA)
- Gastroenterology & Hepatology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE8701765A SE8701765L (en) | 1987-04-28 | 1987-04-28 | METHOD OF ANALYSIS AND AGENTS FOR THIS |
SE8701765 | 1987-04-28 |
Publications (1)
Publication Number | Publication Date |
---|---|
AU1711088A true AU1711088A (en) | 1988-12-02 |
Family
ID=20368350
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU17110/88A Abandoned AU1711088A (en) | 1987-04-28 | 1988-04-28 | Hiv related human retrovirus strain with cloned nucleotide sequence and applications thereof |
Country Status (3)
Country | Link |
---|---|
AU (1) | AU1711088A (en) |
SE (1) | SE8701765L (en) |
WO (1) | WO1988008449A1 (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU625970B2 (en) * | 1988-06-09 | 1992-07-23 | Innogenetics N.V. | Hiv-3 retrovirus and its use |
AU648983B2 (en) * | 1989-03-31 | 1994-05-12 | United States of America, as represented by the Secretary, U.S. Department of Commerce, The | Characterization of a replication competent human immunodeficiency type 2 proviral clone |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2110283T3 (en) * | 1989-05-31 | 1998-02-01 | Pasteur Institut | ANTIBODY PROTEINS AND GLYCOPROTEINS OF HIV-2 EHO RETROVIRUSES DIRECTED AGAINST THEM - APPLICATION FOR DIAGNOSIS. |
DE4405810A1 (en) | 1994-02-23 | 1995-08-24 | Behringwerke Ag | Peptides derived from a retrovirus from the HIV group and their use |
US6001558A (en) * | 1997-06-25 | 1999-12-14 | Ortho Clinical Diagnostics, Inc. | Amplification and detection of HIV-1 and/or HIV 2 |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB8324800D0 (en) * | 1983-09-15 | 1983-10-19 | Pasteur Institut | Antigens |
DE3690028T (en) * | 1985-01-15 | 1987-03-12 | ||
EP0249611A4 (en) * | 1985-11-14 | 1988-04-26 | Harvard College | T-lymphotrophic virus. |
ATE47725T1 (en) * | 1986-01-22 | 1989-11-15 | Pasteur Institut | HIV-2 TYPE RETROVIRUS, APPROPRIATE TO CAUSE AIDS, AND ITS ANTIGENIC AND NUCLEIC ACID COMPONENTS. |
US4752565A (en) * | 1986-04-07 | 1988-06-21 | The United States Of America As Represented By The Department Of Health And Human Services | Cell line producing AIDS viral antigens without producing infectious virus particles |
EP0250128A3 (en) * | 1986-06-18 | 1988-06-08 | American Registry of Pathology | Novel virus isolated from patients with aids |
US5030714A (en) * | 1986-06-23 | 1991-07-09 | Institut Pasteur | Variant of LAV viruses |
-
1987
- 1987-04-28 SE SE8701765A patent/SE8701765L/en not_active Application Discontinuation
-
1988
- 1988-04-28 AU AU17110/88A patent/AU1711088A/en not_active Abandoned
- 1988-04-28 WO PCT/SE1988/000218 patent/WO1988008449A1/en unknown
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU625970B2 (en) * | 1988-06-09 | 1992-07-23 | Innogenetics N.V. | Hiv-3 retrovirus and its use |
AU648983B2 (en) * | 1989-03-31 | 1994-05-12 | United States of America, as represented by the Secretary, U.S. Department of Commerce, The | Characterization of a replication competent human immunodeficiency type 2 proviral clone |
Also Published As
Publication number | Publication date |
---|---|
SE8701765D0 (en) | 1987-04-28 |
SE8701765L (en) | 1988-10-29 |
WO1988008449A1 (en) | 1988-11-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB2210621B (en) | Two micron yeast plasmid vector | |
AU8215687A (en) | Adhesives, their preparation and use | |
AU6891187A (en) | Retrovirus of the hiv-2 type susceptible of inducing aids, and its antigenic and nucleic constituents | |
AU617088B2 (en) | Peptides involved in the pathogenesis of hiv infection | |
AU600300B2 (en) | Polyfluoropolyethers having pendant perfluoroalkoxy groups | |
NZ219909A (en) | Recombinant vaccinia virus expressing human (hiv) retrovirus gene | |
AU2157888A (en) | Novel hiv proteins and peptides useful in the diagnosis, prophylaxis or therapy of aids | |
AU588665B2 (en) | Alloy and product made therefrom | |
AU3006789A (en) | Expression of hiv binding proteins | |
AU1711088A (en) | Hiv related human retrovirus strain with cloned nucleotide sequence and applications thereof | |
AU2156588A (en) | Tetrahydroindazolyl-benzoxazines, their production and use | |
EP0363436A4 (en) | Cloned protein g variant genes and the protein g variants expressed therefrom. | |
AU4751990A (en) | Nucleotides encoding human b1, 4-galactosyltransferase and uses thereof | |
AU1164588A (en) | Nucleotide analogs, their production and use | |
AU7539087A (en) | Flat biomedical electrode | |
AU2579688A (en) | Expression of hiv proteins in e. coli and s. cerevisiae | |
AU8042587A (en) | Cloning and use of the transaminase gene ilve | |
AU628643B2 (en) | Strain of myxococcus | |
AU1884788A (en) | Alpha-fluoroketones, their preparation, and intermediates | |
AU3335689A (en) | Recombinant gag precursor of hiv, product, process, and use as aids vaccine | |
AU2761988A (en) | Malaria-specific DNA sequences, expression products thereof, and the use thereof | |
AU591457B2 (en) | Use of a DNA-sequence for expression: a DNA structure and expression vector incorporating the given DNA sequence | |
AU2348088A (en) | Bacterial strain | |
AU1676288A (en) | Human immunodeficiency virus gag-encoded proteins | |
AU1819988A (en) | Pallett construction |